Global Haemophilus b Conjugate Vaccine (Hib) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 70

Published Date: 07 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Haemophilus b Conjugate Vaccine (Hib) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Haemophilus b Conjugate Vaccine (Hib) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Haemophilus b Conjugate Vaccine (Hib) market size and forecasts, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Haemophilus b Conjugate Vaccine (Hib) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Haemophilus b Conjugate Vaccine (Hib) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Haemophilus b Conjugate Vaccine (Hib) market shares of main players, shipments in revenue ($ Million), sales quantity (K Doses), and ASP (US$/Dose), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Haemophilus b Conjugate Vaccine (Hib)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Haemophilus b Conjugate Vaccine (Hib) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Pasteur, SA, GSK and Merck. etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Haemophilus b Conjugate Vaccine (Hib) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Inactivated Vaccine
    Live Attenuated Vaccine

Market segment by Application
    Government Institution
    Private Sector
    Other

Major players covered
    Sanofi Pasteur, SA
    GSK
    Merck

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Haemophilus b Conjugate Vaccine (Hib) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Haemophilus b Conjugate Vaccine (Hib), with price, sales, revenue and global market share of Haemophilus b Conjugate Vaccine (Hib) from 2018 to 2023.
Chapter 3, the Haemophilus b Conjugate Vaccine (Hib) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Haemophilus b Conjugate Vaccine (Hib) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Haemophilus b Conjugate Vaccine (Hib) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Haemophilus b Conjugate Vaccine (Hib).
Chapter 14 and 15, to describe Haemophilus b Conjugate Vaccine (Hib) sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Haemophilus b Conjugate Vaccine (Hib)
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Inactivated Vaccine
        1.3.3 Live Attenuated Vaccine
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Government Institution
        1.4.3 Private Sector
        1.4.4 Other
    1.5 Global Haemophilus b Conjugate Vaccine (Hib) Market Size & Forecast
        1.5.1 Global Haemophilus b Conjugate Vaccine (Hib) Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Haemophilus b Conjugate Vaccine (Hib) Sales Quantity (2018-2029)
        1.5.3 Global Haemophilus b Conjugate Vaccine (Hib) Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Sanofi Pasteur, SA
        2.1.1 Sanofi Pasteur, SA Details
        2.1.2 Sanofi Pasteur, SA Major Business
        2.1.3 Sanofi Pasteur, SA Haemophilus b Conjugate Vaccine (Hib) Product and Services
        2.1.4 Sanofi Pasteur, SA Haemophilus b Conjugate Vaccine (Hib) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Sanofi Pasteur, SA Recent Developments/Updates
    2.2 GSK
        2.2.1 GSK Details
        2.2.2 GSK Major Business
        2.2.3 GSK Haemophilus b Conjugate Vaccine (Hib) Product and Services
        2.2.4 GSK Haemophilus b Conjugate Vaccine (Hib) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 GSK Recent Developments/Updates
    2.3 Merck
        2.3.1 Merck Details
        2.3.2 Merck Major Business
        2.3.3 Merck Haemophilus b Conjugate Vaccine (Hib) Product and Services
        2.3.4 Merck Haemophilus b Conjugate Vaccine (Hib) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Merck Recent Developments/Updates

3 Competitive Environment: Haemophilus b Conjugate Vaccine (Hib) by Manufacturer
    3.1 Global Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Haemophilus b Conjugate Vaccine (Hib) Revenue by Manufacturer (2018-2023)
    3.3 Global Haemophilus b Conjugate Vaccine (Hib) Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Haemophilus b Conjugate Vaccine (Hib) by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Haemophilus b Conjugate Vaccine (Hib) Manufacturer Market Share in 2022
        3.4.2 Top 6 Haemophilus b Conjugate Vaccine (Hib) Manufacturer Market Share in 2022
    3.5 Haemophilus b Conjugate Vaccine (Hib) Market: Overall Company Footprint Analysis
        3.5.1 Haemophilus b Conjugate Vaccine (Hib) Market: Region Footprint
        3.5.2 Haemophilus b Conjugate Vaccine (Hib) Market: Company Product Type Footprint
        3.5.3 Haemophilus b Conjugate Vaccine (Hib) Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Haemophilus b Conjugate Vaccine (Hib) Market Size by Region
        4.1.1 Global Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Region (2018-2029)
        4.1.2 Global Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Region (2018-2029)
        4.1.3 Global Haemophilus b Conjugate Vaccine (Hib) Average Price by Region (2018-2029)
    4.2 North America Haemophilus b Conjugate Vaccine (Hib) Consumption Value (2018-2029)
    4.3 Europe Haemophilus b Conjugate Vaccine (Hib) Consumption Value (2018-2029)
    4.4 Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Consumption Value (2018-2029)
    4.5 South America Haemophilus b Conjugate Vaccine (Hib) Consumption Value (2018-2029)
    4.6 Middle East and Africa Haemophilus b Conjugate Vaccine (Hib) Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Type (2018-2029)
    5.2 Global Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Type (2018-2029)
    5.3 Global Haemophilus b Conjugate Vaccine (Hib) Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Application (2018-2029)
    6.2 Global Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Application (2018-2029)
    6.3 Global Haemophilus b Conjugate Vaccine (Hib) Average Price by Application (2018-2029)

7 North America
    7.1 North America Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Type (2018-2029)
    7.2 North America Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Application (2018-2029)
    7.3 North America Haemophilus b Conjugate Vaccine (Hib) Market Size by Country
        7.3.1 North America Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Country (2018-2029)
        7.3.2 North America Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Type (2018-2029)
    8.2 Europe Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Application (2018-2029)
    8.3 Europe Haemophilus b Conjugate Vaccine (Hib) Market Size by Country
        8.3.1 Europe Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Country (2018-2029)
        8.3.2 Europe Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Market Size by Region
        9.3.1 Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Type (2018-2029)
    10.2 South America Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Application (2018-2029)
    10.3 South America Haemophilus b Conjugate Vaccine (Hib) Market Size by Country
        10.3.1 South America Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Country (2018-2029)
        10.3.2 South America Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Market Size by Country
        11.3.1 Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Haemophilus b Conjugate Vaccine (Hib) Market Drivers
    12.2 Haemophilus b Conjugate Vaccine (Hib) Market Restraints
    12.3 Haemophilus b Conjugate Vaccine (Hib) Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Haemophilus b Conjugate Vaccine (Hib) and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Haemophilus b Conjugate Vaccine (Hib)
    13.3 Haemophilus b Conjugate Vaccine (Hib) Production Process
    13.4 Haemophilus b Conjugate Vaccine (Hib) Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Haemophilus b Conjugate Vaccine (Hib) Typical Distributors
    14.3 Haemophilus b Conjugate Vaccine (Hib) Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Sanofi Pasteur, SA Basic Information, Manufacturing Base and Competitors
    Table 4. Sanofi Pasteur, SA Major Business
    Table 5. Sanofi Pasteur, SA Haemophilus b Conjugate Vaccine (Hib) Product and Services
    Table 6. Sanofi Pasteur, SA Haemophilus b Conjugate Vaccine (Hib) Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Sanofi Pasteur, SA Recent Developments/Updates
    Table 8. GSK Basic Information, Manufacturing Base and Competitors
    Table 9. GSK Major Business
    Table 10. GSK Haemophilus b Conjugate Vaccine (Hib) Product and Services
    Table 11. GSK Haemophilus b Conjugate Vaccine (Hib) Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. GSK Recent Developments/Updates
    Table 13. Merck Basic Information, Manufacturing Base and Competitors
    Table 14. Merck Major Business
    Table 15. Merck Haemophilus b Conjugate Vaccine (Hib) Product and Services
    Table 16. Merck Haemophilus b Conjugate Vaccine (Hib) Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Merck Recent Developments/Updates
    Table 18. Global Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Manufacturer (2018-2023) & (K Doses)
    Table 19. Global Haemophilus b Conjugate Vaccine (Hib) Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 20. Global Haemophilus b Conjugate Vaccine (Hib) Average Price by Manufacturer (2018-2023) & (US$/Dose)
    Table 21. Market Position of Manufacturers in Haemophilus b Conjugate Vaccine (Hib), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 22. Head Office and Haemophilus b Conjugate Vaccine (Hib) Production Site of Key Manufacturer
    Table 23. Haemophilus b Conjugate Vaccine (Hib) Market: Company Product Type Footprint
    Table 24. Haemophilus b Conjugate Vaccine (Hib) Market: Company Product Application Footprint
    Table 25. Haemophilus b Conjugate Vaccine (Hib) New Market Entrants and Barriers to Market Entry
    Table 26. Haemophilus b Conjugate Vaccine (Hib) Mergers, Acquisition, Agreements, and Collaborations
    Table 27. Global Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Region (2018-2023) & (K Doses)
    Table 28. Global Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Region (2024-2029) & (K Doses)
    Table 29. Global Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Region (2018-2023) & (USD Million)
    Table 30. Global Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Region (2024-2029) & (USD Million)
    Table 31. Global Haemophilus b Conjugate Vaccine (Hib) Average Price by Region (2018-2023) & (US$/Dose)
    Table 32. Global Haemophilus b Conjugate Vaccine (Hib) Average Price by Region (2024-2029) & (US$/Dose)
    Table 33. Global Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Type (2018-2023) & (K Doses)
    Table 34. Global Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Type (2024-2029) & (K Doses)
    Table 35. Global Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Type (2018-2023) & (USD Million)
    Table 36. Global Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Type (2024-2029) & (USD Million)
    Table 37. Global Haemophilus b Conjugate Vaccine (Hib) Average Price by Type (2018-2023) & (US$/Dose)
    Table 38. Global Haemophilus b Conjugate Vaccine (Hib) Average Price by Type (2024-2029) & (US$/Dose)
    Table 39. Global Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Application (2018-2023) & (K Doses)
    Table 40. Global Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Application (2024-2029) & (K Doses)
    Table 41. Global Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Application (2018-2023) & (USD Million)
    Table 42. Global Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Application (2024-2029) & (USD Million)
    Table 43. Global Haemophilus b Conjugate Vaccine (Hib) Average Price by Application (2018-2023) & (US$/Dose)
    Table 44. Global Haemophilus b Conjugate Vaccine (Hib) Average Price by Application (2024-2029) & (US$/Dose)
    Table 45. North America Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Type (2018-2023) & (K Doses)
    Table 46. North America Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Type (2024-2029) & (K Doses)
    Table 47. North America Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Application (2018-2023) & (K Doses)
    Table 48. North America Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Application (2024-2029) & (K Doses)
    Table 49. North America Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Country (2018-2023) & (K Doses)
    Table 50. North America Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Country (2024-2029) & (K Doses)
    Table 51. North America Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Country (2018-2023) & (USD Million)
    Table 52. North America Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Country (2024-2029) & (USD Million)
    Table 53. Europe Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Type (2018-2023) & (K Doses)
    Table 54. Europe Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Type (2024-2029) & (K Doses)
    Table 55. Europe Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Application (2018-2023) & (K Doses)
    Table 56. Europe Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Application (2024-2029) & (K Doses)
    Table 57. Europe Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Country (2018-2023) & (K Doses)
    Table 58. Europe Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Country (2024-2029) & (K Doses)
    Table 59. Europe Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Country (2018-2023) & (USD Million)
    Table 60. Europe Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Country (2024-2029) & (USD Million)
    Table 61. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Type (2018-2023) & (K Doses)
    Table 62. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Type (2024-2029) & (K Doses)
    Table 63. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Application (2018-2023) & (K Doses)
    Table 64. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Application (2024-2029) & (K Doses)
    Table 65. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Region (2018-2023) & (K Doses)
    Table 66. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Region (2024-2029) & (K Doses)
    Table 67. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Region (2018-2023) & (USD Million)
    Table 68. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Region (2024-2029) & (USD Million)
    Table 69. South America Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Type (2018-2023) & (K Doses)
    Table 70. South America Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Type (2024-2029) & (K Doses)
    Table 71. South America Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Application (2018-2023) & (K Doses)
    Table 72. South America Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Application (2024-2029) & (K Doses)
    Table 73. South America Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Country (2018-2023) & (K Doses)
    Table 74. South America Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Country (2024-2029) & (K Doses)
    Table 75. South America Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Country (2018-2023) & (USD Million)
    Table 76. South America Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Country (2024-2029) & (USD Million)
    Table 77. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Type (2018-2023) & (K Doses)
    Table 78. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Type (2024-2029) & (K Doses)
    Table 79. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Application (2018-2023) & (K Doses)
    Table 80. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Application (2024-2029) & (K Doses)
    Table 81. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Region (2018-2023) & (K Doses)
    Table 82. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Sales Quantity by Region (2024-2029) & (K Doses)
    Table 83. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Region (2018-2023) & (USD Million)
    Table 84. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Region (2024-2029) & (USD Million)
    Table 85. Haemophilus b Conjugate Vaccine (Hib) Raw Material
    Table 86. Key Manufacturers of Haemophilus b Conjugate Vaccine (Hib) Raw Materials
    Table 87. Haemophilus b Conjugate Vaccine (Hib) Typical Distributors
    Table 88. Haemophilus b Conjugate Vaccine (Hib) Typical Customers
List of Figures
    Figure 1. Haemophilus b Conjugate Vaccine (Hib) Picture
    Figure 2. Global Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Haemophilus b Conjugate Vaccine (Hib) Consumption Value Market Share by Type in 2022
    Figure 4. Inactivated Vaccine Examples
    Figure 5. Live Attenuated Vaccine Examples
    Figure 6. Global Haemophilus b Conjugate Vaccine (Hib) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Haemophilus b Conjugate Vaccine (Hib) Consumption Value Market Share by Application in 2022
    Figure 8. Government Institution Examples
    Figure 9. Private Sector Examples
    Figure 10. Other Examples
    Figure 11. Global Haemophilus b Conjugate Vaccine (Hib) Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Haemophilus b Conjugate Vaccine (Hib) Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Haemophilus b Conjugate Vaccine (Hib) Sales Quantity (2018-2029) & (K Doses)
    Figure 14. Global Haemophilus b Conjugate Vaccine (Hib) Average Price (2018-2029) & (US$/Dose)
    Figure 15. Global Haemophilus b Conjugate Vaccine (Hib) Sales Quantity Market Share by Manufacturer in 2022
    Figure 16. Global Haemophilus b Conjugate Vaccine (Hib) Consumption Value Market Share by Manufacturer in 2022
    Figure 17. Producer Shipments of Haemophilus b Conjugate Vaccine (Hib) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 18. Top 3 Haemophilus b Conjugate Vaccine (Hib) Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Top 6 Haemophilus b Conjugate Vaccine (Hib) Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Global Haemophilus b Conjugate Vaccine (Hib) Sales Quantity Market Share by Region (2018-2029)
    Figure 21. Global Haemophilus b Conjugate Vaccine (Hib) Consumption Value Market Share by Region (2018-2029)
    Figure 22. North America Haemophilus b Conjugate Vaccine (Hib) Consumption Value (2018-2029) & (USD Million)
    Figure 23. Europe Haemophilus b Conjugate Vaccine (Hib) Consumption Value (2018-2029) & (USD Million)
    Figure 24. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Consumption Value (2018-2029) & (USD Million)
    Figure 25. South America Haemophilus b Conjugate Vaccine (Hib) Consumption Value (2018-2029) & (USD Million)
    Figure 26. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Consumption Value (2018-2029) & (USD Million)
    Figure 27. Global Haemophilus b Conjugate Vaccine (Hib) Sales Quantity Market Share by Type (2018-2029)
    Figure 28. Global Haemophilus b Conjugate Vaccine (Hib) Consumption Value Market Share by Type (2018-2029)
    Figure 29. Global Haemophilus b Conjugate Vaccine (Hib) Average Price by Type (2018-2029) & (US$/Dose)
    Figure 30. Global Haemophilus b Conjugate Vaccine (Hib) Sales Quantity Market Share by Application (2018-2029)
    Figure 31. Global Haemophilus b Conjugate Vaccine (Hib) Consumption Value Market Share by Application (2018-2029)
    Figure 32. Global Haemophilus b Conjugate Vaccine (Hib) Average Price by Application (2018-2029) & (US$/Dose)
    Figure 33. North America Haemophilus b Conjugate Vaccine (Hib) Sales Quantity Market Share by Type (2018-2029)
    Figure 34. North America Haemophilus b Conjugate Vaccine (Hib) Sales Quantity Market Share by Application (2018-2029)
    Figure 35. North America Haemophilus b Conjugate Vaccine (Hib) Sales Quantity Market Share by Country (2018-2029)
    Figure 36. North America Haemophilus b Conjugate Vaccine (Hib) Consumption Value Market Share by Country (2018-2029)
    Figure 37. United States Haemophilus b Conjugate Vaccine (Hib) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Canada Haemophilus b Conjugate Vaccine (Hib) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Mexico Haemophilus b Conjugate Vaccine (Hib) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Europe Haemophilus b Conjugate Vaccine (Hib) Sales Quantity Market Share by Type (2018-2029)
    Figure 41. Europe Haemophilus b Conjugate Vaccine (Hib) Sales Quantity Market Share by Application (2018-2029)
    Figure 42. Europe Haemophilus b Conjugate Vaccine (Hib) Sales Quantity Market Share by Country (2018-2029)
    Figure 43. Europe Haemophilus b Conjugate Vaccine (Hib) Consumption Value Market Share by Country (2018-2029)
    Figure 44. Germany Haemophilus b Conjugate Vaccine (Hib) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. France Haemophilus b Conjugate Vaccine (Hib) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. United Kingdom Haemophilus b Conjugate Vaccine (Hib) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Russia Haemophilus b Conjugate Vaccine (Hib) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Italy Haemophilus b Conjugate Vaccine (Hib) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Quantity Market Share by Type (2018-2029)
    Figure 50. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Quantity Market Share by Application (2018-2029)
    Figure 51. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Sales Quantity Market Share by Region (2018-2029)
    Figure 52. Asia-Pacific Haemophilus b Conjugate Vaccine (Hib) Consumption Value Market Share by Region (2018-2029)
    Figure 53. China Haemophilus b Conjugate Vaccine (Hib) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Japan Haemophilus b Conjugate Vaccine (Hib) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Korea Haemophilus b Conjugate Vaccine (Hib) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. India Haemophilus b Conjugate Vaccine (Hib) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Southeast Asia Haemophilus b Conjugate Vaccine (Hib) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Australia Haemophilus b Conjugate Vaccine (Hib) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. South America Haemophilus b Conjugate Vaccine (Hib) Sales Quantity Market Share by Type (2018-2029)
    Figure 60. South America Haemophilus b Conjugate Vaccine (Hib) Sales Quantity Market Share by Application (2018-2029)
    Figure 61. South America Haemophilus b Conjugate Vaccine (Hib) Sales Quantity Market Share by Country (2018-2029)
    Figure 62. South America Haemophilus b Conjugate Vaccine (Hib) Consumption Value Market Share by Country (2018-2029)
    Figure 63. Brazil Haemophilus b Conjugate Vaccine (Hib) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Argentina Haemophilus b Conjugate Vaccine (Hib) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Sales Quantity Market Share by Type (2018-2029)
    Figure 66. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Sales Quantity Market Share by Application (2018-2029)
    Figure 67. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Sales Quantity Market Share by Region (2018-2029)
    Figure 68. Middle East & Africa Haemophilus b Conjugate Vaccine (Hib) Consumption Value Market Share by Region (2018-2029)
    Figure 69. Turkey Haemophilus b Conjugate Vaccine (Hib) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Egypt Haemophilus b Conjugate Vaccine (Hib) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Saudi Arabia Haemophilus b Conjugate Vaccine (Hib) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. South Africa Haemophilus b Conjugate Vaccine (Hib) Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Haemophilus b Conjugate Vaccine (Hib) Market Drivers
    Figure 74. Haemophilus b Conjugate Vaccine (Hib) Market Restraints
    Figure 75. Haemophilus b Conjugate Vaccine (Hib) Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Haemophilus b Conjugate Vaccine (Hib) in 2022
    Figure 78. Manufacturing Process Analysis of Haemophilus b Conjugate Vaccine (Hib)
    Figure 79. Haemophilus b Conjugate Vaccine (Hib) Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Sanofi Pasteur, SA
GSK
Merck

Related Reports

Global Haemophilus b Conjugate Vaccine (Hib) Supply, Demand and Key Producers, 2023-2029

Global Haemophilus b Conjugate Vaccine (Hib) Supply, Demand and Key Producers, 2023-2029

date 19 Mar 2023

date Pharma & Healthcare

The global Haemophilus b Conjugate Vaccine (Hib) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Haemophilus b Conjugate Vaccine (Hib) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Haemophilus b Conjugate Vaccine (Hib) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 20 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Haemophilus b Conjugate Vaccine (Hib) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

haemophilus b conjugate vaccine hib

Haemophilus b Conjugate Vaccine (Hib)

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>